cp094 has been researched along with Carcinoma, Basal Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alyahya, R; Campbell, SM; Curnow, A; Horton, S; Morton, CA; Pye, A | 1 |
| Albertin, A; La Colla, L; Mangano, A | 1 |
| Campbell, SM; Curnow, A | 1 |
| Campbell, S; Curnow, A; Pye, A | 1 |
2 trial(s) available for cp094 and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Female; Humans; Iron Chelating Agents; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Skin Neoplasms; Treatment Outcome | 2008 |
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Line, Tumor; Humans; In Vitro Techniques; Iron Chelating Agents; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Pyridones; Skin Neoplasms | 2008 |
2 other study(ies) available for cp094 and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: when statistics make a difference.
Topics: Carcinoma, Basal Cell; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Sample Size; Skin Neoplasms | 2009 |
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacologica
Topics: Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Skin Neoplasms | 2010 |